Clinical use of biomarkers in neurodegenerative disorders

The prevalence of neurodegenerative disorders is increasing dramatically and one of the major challenges today is the need of early and accurate diagnosis, the other is the need of more effective therapies -in turn the development of such therapies also requires early and accurate diagnosis-. The ma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Frontiers Research Topics
Autor principal: Manuel Menendez-Gonzalez
Formato: Livro
Idioma:Inglês
Publicado em: Frontiers Media SA 2014
Assuntos:
RC321-571
Q1-390
thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSA Life sciences: general issues::PSAN Neurosciences
Neurodegenerative Diseases
neurodegenerative disease
Parkinson's disease
MTAi
biomarker
Huntington's disease
CSF biomarkers
Frontotemporal dementia (FTD)
Acesso em linha:https://directory.doabooks.org/handle/20.500.12854/43405
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados